Why the study?
With population aging, the economic burden of HF is expected to increase, but little is known about hospitalization costs associated with HF in Japan.
Heart failure accounts for the highest hospitalization costs among acute cardiovascular diseases in Japan, with a disproportionate burden among patients over 75 years of age.
HF drives 44% of acute CVD hospitalization costs in Japan, especially elderly; cross-sectional data leaves open targeted cost-reduction trials.
BACKGROUND: With aging of the population, the economic burden associated with heart failure (HF) is expected to increase. However, little is known about the hospitalization costs associated with HF in Japan. METHODS AND RESULTS: In this cross-sectional study, using data from The Japanese Registry of All Cardiac and Vascular Diseases (JROAD) and JROAD-Diagnosis Procedure Combination databases between 2012 and 2014, we evaluated hospitalization costs for acute cardiovascular diseases (CVDs), including HF. A total of $1,187 million/year (44% of the hospitalization costs for acute CVDs) was spent on patients with HF. We identified 273,865 patients with HF and the median cost per patient was $8,089 ($5,362-12,787) per episode. The top 1% of spenders accounted for 8% ($80 million/year), and the top 5% of spenders accounted for 22% ($229 million/year) of the entire cost associated with HF. The costs associated with HF for patients over 75 years of age accounted for 68% of the total cost. CONCLUSIONS: The costs associated with HF were higher than the hospitalization cost for any other acute CVD in Japan. Understanding how the total hospitalization cost is distributed may allow health providers to utilize limited resources more effectively for patients with HF.
No takes yet. Share an insight, caveat, or question.
Kanaoka et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: